Azelis Appoints Evy Hellinckx as new Strategy & Business Development Director EMEA

Azelis announced the appointment of Evy Hellinckx as Strategy & Business Development Director EMEA. In this role, Hellinckx will drive the long term strategies for the Group’s markets and continue to improve our principal management and development in EMEA. Hellinckx will report to Anna Bertona, Chief Operating Officer EMEA.

Anna Bertona comments: “We have significantly grown and expanded geographically over the last few years and we recognized the need to realign internally. As a result, we now have principal management and strategy development in EMEA centralized in one function, ensuring better alignment and focus.”

Hellinckx holds a master degree in Commercial Engineering from the Catholic University in Leuven, Belgium. She has a track record in strategy, business development, marketing and sales, having worked at a major strategic consultancy group for 10 years focusing on top line growth in B2C and B2B2C industries. In her last assignment Hellinckx was Strategic Account Manager at a leading global pharmaceutical producer, responsible for one of the largest regions in Belgium.

This completes the organizational changes that were announced earlier this year when Anna Bertona was appointed Chief Operating Officer EMEA and Laurent Nataf CEO and President Asia Pacific.

Meist gelesen

Photo
14.11.2024 • News

BÜFA schafft Basis für künftiges Wachstum

Die chemische Industrie in Deutschland sieht sich zunehmend vor enormen Herausforderungen. Die aktuellen wirtschaftspolitischen Rahmenbedingungen erschweren es, die ökonomische Kraft im Inland voll auszuschöpfen. In diesem anspruchsvollen Umfeld agiert auch das Oldenburger Chemieunternehmen BÜFA und rüstet sich, seine Resilienz gegenüber möglichen komplexen und unvorhersehbaren Marktschwankungen im kommenden Jahr weiter zu stärken.

Photo
19.12.2024 • News

Covestro-Aktionäre stimmen Übernahme durch ADNOC zu

ADNOC International erhält insgesamt 91,3 % der Covestro-Aktien. Bereits nach Ende der regulären Annahmefrist am 27. November 2024 hatte das Übernahmeangebot die Mindestannahmequote mit rund 70 % deutlich überschritten.